313 related articles for article (PubMed ID: 24958881)
1. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.
Srinivasan P; Ekanem E; Diouf A; Tonkin ML; Miura K; Boulanger MJ; Long CA; Narum DL; Miller LH
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10311-6. PubMed ID: 24958881
[TBL] [Abstract][Full Text] [Related]
2. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
[TBL] [Abstract][Full Text] [Related]
3. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
[TBL] [Abstract][Full Text] [Related]
4. Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
Biswas S; Spencer AJ; Forbes EK; Gilbert SC; Holder AA; Hill AV; Draper SJ
J Immunol; 2012 May; 188(10):5041-53. PubMed ID: 22504652
[TBL] [Abstract][Full Text] [Related]
5. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.
Qian F; Wu Y; Muratova O; Zhou H; Dobrescu G; Duggan P; Lynn L; Song G; Zhang Y; Reiter K; MacDonald N; Narum DL; Long CA; Miller LH; Saul A; Mullen GE
Vaccine; 2007 May; 25(20):3923-33. PubMed ID: 17428587
[TBL] [Abstract][Full Text] [Related]
6. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.
Kennedy MC; Wang J; Zhang Y; Miles AP; Chitsaz F; Saul A; Long CA; Miller LH; Stowers AW
Infect Immun; 2002 Dec; 70(12):6948-60. PubMed ID: 12438374
[TBL] [Abstract][Full Text] [Related]
8. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
Chuang I; Sedegah M; Cicatelli S; Spring M; Polhemus M; Tamminga C; Patterson N; Guerrero M; Bennett JW; McGrath S; Ganeshan H; Belmonte M; Farooq F; Abot E; Banania JG; Huang J; Newcomer R; Rein L; Litilit D; Richie NO; Wood C; Murphy J; Sauerwein R; Hermsen CC; McCoy AJ; Kamau E; Cummings J; Komisar J; Sutamihardja A; Shi M; Epstein JE; Maiolatesi S; Tosh D; Limbach K; Angov E; Bergmann-Leitner E; Bruder JT; Doolan DL; King CR; Carucci D; Dutta S; Soisson L; Diggs C; Hollingdale MR; Ockenhouse CF; Richie TL
PLoS One; 2013; 8(2):e55571. PubMed ID: 23457473
[TBL] [Abstract][Full Text] [Related]
9. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
Dutta S; Dlugosz LS; Drew DR; Ge X; Ababacar D; Rovira YI; Moch JK; Shi M; Long CA; Foley M; Beeson JG; Anders RF; Miura K; Haynes JD; Batchelor AH
PLoS Pathog; 2013; 9(12):e1003840. PubMed ID: 24385910
[TBL] [Abstract][Full Text] [Related]
10. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine.
Ouattara A; Mu J; Takala-Harrison S; Saye R; Sagara I; Dicko A; Niangaly A; Duan J; Ellis RD; Miller LH; Su XZ; Plowe CV; Doumbo OK
Malar J; 2010 Jun; 9():175. PubMed ID: 20565971
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
Narum DL; Ogun SA; Batchelor AH; Holder AA
Infect Immun; 2006 Oct; 74(10):5529-36. PubMed ID: 16988228
[TBL] [Abstract][Full Text] [Related]
12. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naïve adults.
Remarque EJ; Roestenberg M; Younis S; Walraven V; van der Werff N; Faber BW; Leroy O; Sauerwein R; Kocken CH; Thomas AW
PLoS One; 2012; 7(6):e38898. PubMed ID: 22768052
[TBL] [Abstract][Full Text] [Related]
14. Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.
Faber BW; Remarque EJ; Morgan WD; Kocken CH; Holder AA; Thomas AW
Infect Immun; 2007 Dec; 75(12):5947-55. PubMed ID: 17938224
[TBL] [Abstract][Full Text] [Related]
15. Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.
Miura K; Herrera R; Diouf A; Zhou H; Mu J; Hu Z; MacDonald NJ; Reiter K; Nguyen V; Shimp RL; Singh K; Narum DL; Long CA; Miller LH
Infect Immun; 2013 May; 81(5):1491-501. PubMed ID: 23429537
[TBL] [Abstract][Full Text] [Related]
16. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites.
Richard D; MacRaild CA; Riglar DT; Chan JA; Foley M; Baum J; Ralph SA; Norton RS; Cowman AF
J Biol Chem; 2010 May; 285(19):14815-22. PubMed ID: 20228060
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.
Stowers AW; Kennedy MC; Keegan BP; Saul A; Long CA; Miller LH
Infect Immun; 2002 Dec; 70(12):6961-7. PubMed ID: 12438375
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
Sirima SB; Durier C; Kara L; Houard S; Gansane A; Loulergue P; Bahuaud M; Benhamouda N; Nebié I; Faber B; Remarque E; Launay O;
Vaccine; 2017 Oct; 35(45):6218-6227. PubMed ID: 28947345
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.
Kusi KA; Faber BW; Thomas AW; Remarque EJ
PLoS One; 2009 Dec; 4(12):e8110. PubMed ID: 19956619
[TBL] [Abstract][Full Text] [Related]
20. Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
Leite JA; Bargieri DY; Carvalho BO; Albrecht L; Lopes SC; Kayano AC; Farias AS; Chia WN; Claser C; Malleret B; Russell B; Castiñeiras C; Santos LM; Brocchi M; Wunderlich G; Soares IS; Rodrigues MM; Rénia L; Costa FT
Infect Immun; 2015 Oct; 83(10):3781-92. PubMed ID: 26169268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
